Enhancing Vinblastine Effectiveness with Phenytoin and Okadaic Acid
Author Information
Author(s): K-I Kawamura, D Grabowski, K Weizer, R Bukowski, R Ganapathi
Primary Institution: Cleveland Clinic Foundation
Hypothesis
Can phenytoin and okadaic acid enhance the cytotoxic effects of vinblastine in human tumor cells?
Conclusion
Phenytoin and okadaic acid significantly enhance the cytotoxicity of vinblastine in human leukemia and lung cancer cells, leading to prolonged growth arrest and apoptosis.
Supporting Evidence
- Phenytoin enhances vinblastine cytotoxicity without binding to P-glycoprotein.
- Okadaic acid mimics phenytoin's effects on vinblastine cytotoxicity.
- Both drugs lead to increased apoptosis in treated cells.
- The combination of vinblastine and either drug results in persistent growth arrest.
Takeaway
This study shows that two drugs, phenytoin and okadaic acid, can make a cancer treatment called vinblastine work better by causing more cancer cells to die.
Methodology
Human leukemia HL-60 and lung cancer NSCLC-3 cells were treated with vinblastine, phenytoin, or okadaic acid, and analyzed for cytotoxicity, mitotic arrest, and apoptosis.
Limitations
The study primarily focuses on specific cancer cell lines and may not generalize to all types of tumors.
Participant Demographics
Human leukemia HL-60 cells and non-small-cell lung carcinoma NSCLC-3 cells.
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Want to read the original?
Access the complete publication on the publisher's website